Accelerating clinical trials in transplantation
Charles Craddock, CBE, FRCP(UK), FRCPath, DPhil, of the University of Birmingham, Birmingham, UK, talks about the collective organizational efforts to improve stem cell transplant therapies for the tr... Author: VJHemOnc Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

New models for patient care: advanced pharmacy practitioners
In this video, Dharmisha Chauhan, MPharm, of the Royal Marsden NHS Foundation Trust, London, UK, discusses the aims of her pharmacist and nurse-led clinic for patients with melanoma that are receiving... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Patient symptom and experience trackers
Healthcare technologies and apps are important in supporting patients in their care, and can greatly benefit them in their treatment journey. Jonathan Moshinsky, from uMotif, London, UK, describes the... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Update from the Scottish Cancer Medicines Outcome Programme
Kelly Baillie, of the NHS Greater Glasgow & Clyde, Glasgow, UK, presents the key findings from the Cancer Medicines Outcome Programme, a collaboration between NHS Greater Glasgow and Clyde and the Uni... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

The switch to biosimilar rituximab at UCH: 12 months on
At the 2018 British Oncology Pharmacy Association (BOPA) Annual Symposium, Simon Cheesman, MRPharmS, of University College London, London, UK, presented the experiences at University College Hospital ... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

CPX-351: liposomal daunorubicin and cytarabine for treating high-risk AML
From the British Oncology Pharmacy Association (BOPA) Annual Symposium 2018, held in Birmingham, UK, Simon Cheesman, MRPharmS, from University College London, London, UK, describes the key outcomes fr... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Visibility of Oncology Pharmacists to patients
Oncology Pharmacists play an important role in the treatment and management of patients, but how visible are they to their patients? When Oncology Pharmacist, Shereen Nabhani-Gebara, PharmD, BCOP, fro... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Smart app to allow patients to manage their side effects independently
Managing side effects can be an overwhelming experience for oncology patients, they may be unsure of the severity of their symptoms and could be reluctant to contact their healthcare team. Shereen Nab... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

cancer-druginteractions.org: a comprehensive tool for HCPs
More than half of patients that undergo cancer treatment are estimated to have had at least one potential drug-drug interaction. Here, Jasmine Martin, MSc, of the University of Liverpool, Liverpool, U... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

The emergence of mixed speciality oncology
The increased use of targeted therapies in oncology has introduced a range of new side effects. Emma Foreman, BPharma (Hons) of The Royal Marsden NHS Foundation Trust, London, UK, discusses how these ... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Non-medical prescribing: advice for those starting out
A specialist workshop on non-medical prescribing was hosted at the British Oncology Pharmacy Association (BOPA) Annual Symposium 2018, Birmingham, UK. The aim of this session was to encourage open dis... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

New educational initiatives for BOPA in 2019
The British Oncology Pharmacy Association (BOPA) has a number of exciting educational initiatives in the pipeline for 2019. BOPA committee member, Bryn Thomas, MPharm, from The Royal Marsden NHS Found... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

ATMPs: an innovative class of medicines
Advanced therapy medicinal products (ATMPs) are a novel class of medicines offering treatment options for diseases that currently lack effective therapies. Here, Anne Black, BPharm, of the Newcastle u... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Nurse and pharmacy-led clinics to enhance patient care in oncology
Catherine Oakley, PhD, of Guy's and St Thomas NHS Foundation Trust, London, UK, highlights the benefits of the nurse and pharmacy-led clinics currently being run at Guys Cancer Centre. Ms Oakley exp... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

How to achieve an outstanding clinical pharmacy service
One of the topics discussed at the British Oncology Pharmacy Association (BOPA) Annual Symposium 2018, held in Birmingham, UK, was the question of what should a good, or even outstanding, clinical pha... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Managing non-medical prescribing in the clinic
Non-medical prescribing is one of the important tasks undertaken by Oncology Pharmacists. Bryn Thomas, MPharm, from The Royal Marsden NHS Foundation Trust, London, UK, shares insights from the non-med... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Limitations with AI programs for prescription screening
While artificial intelligence (AI) has revolutionized healthcare by minimizing the element of human error, thus improving efficiency, limitations do still exist. In this video, Bruce Burnett, MMedSci,... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

The role of the pharmacist in ensuring safety of CAR T-cell therapy
As chimeric antigen receptor (CAR) T-cell therapies are patient-specific, this novel treatment type poses unique challenges. From the British Oncology Pharmacy Association (BOPA) Annual Symposium 2018... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Using SMART apps to help manage drug-drug interactions with cancer therapies
Substitutable Medical Apps, Reusable Technologies (SMART) apps have been developed to meet the need for responsiveness in healthcare IT. In this video, Stefanie Krens, MSc, of Radboud University Medic... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Introducing an effective business continuity plan for electronic prescribing: experiences shared from Barts Health NHS Trust
Following the unfortunate IT failures at the Barts Health NHS Trust in 2017, which led to major issues in their electronic prescribing system, it became clear that it was necessary to review processes... Author: VJOncology Added: 10/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 15, 2018 Category: Cancer & Oncology Source Type: podcasts

ALK Inhibitors for Acquired Resistance_ Zykadia and Alectinib [720p](1)
Dr. Nathan Pennell, Cleveland Clinic, discusses acquired resistance to Xalkori in ALK-positive patients, and second generation inhibitors designed to overcome that resistance, such as Zykadia and alec... Author: cancergrace Added: 10/14/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 14, 2018 Category: Cancer & Oncology Source Type: podcasts

Analyzing Biological Data From The Genome Atlas
Pavlos Msaouel, MD, PhD Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center discusses Analyzing Biological Data From The Genome Atlas. At Kidney Cancer... Author: kidneycancer Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Kidney Cancer Histology Variables
Pavlos Msaouel, MD, PhD Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center discusses Kidney Cancer Histology Variables. At Kidney Cancer Association N... Author: kidneycancer Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Rare Kidney Cancer Treatments
Pavlos Msaouel, MD, PhD Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center discusses Rare Kidney Cancer Treatments. At Kidney Cancer Association Natio... Author: kidneycancer Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Optimal Approach To Small Renal Mass
Brian Shuch, MD Associate Professor of Urology at UCLA Discusses the Optimal Approach To Small Renal Mass. At Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL on Septe... Author: kidneycancer Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts

HER2 Mutation Positive NSCLC [720p]
Dr. Nathan Pennell, Cleveland Clinic, describes treatment of NSCLC patients with HER2 mutations using agents such as Gilotrif or Herceptin. Author: cancergrace Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Renal Medullary Carcinoma
Pavlos Msaouel, MD, PhD Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center discusses Renal Medullary Carcinoma. At Kidney Cancer Association National ... Author: kidneycancer Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Immunotherapy In Chromophobe RCC
Pavlos Msaouel, MD, PhD Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center discusses Immunotherapy In Chromophobe RCC. At Kidney Cancer Association Na... Author: kidneycancer Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Predictive Testing for Chemotherapy Responsiveness [720p]
Dr. Nathan Pennell, Cleveland Clinic, evaluates chemotherapy sensitivity assays, describing the difficulties inherent in predicting response to chemotherapy agents. Author: cancergrace Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Detecting Lung Cancer_ Presenting Symptoms [720p]
Dr. Gerard Silvestri, Medical University of South Carolina, describes some of the typical presenting symptoms of lung cancer. Author: cancergrace Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Potential Advantages, Disadvantages and Limitations of Lung Cancer Screening [720p]
GRACE - Global Resource for Advancing Cancer EducationPublished on Feb 24, 2016Dr. Gerard Silvestri, Medical University of South Carolina, discusses the benefits and drawbacks of lung cancer scree... Author: cancergrace Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Why Use Systemic Therapy Before Surgery?
VITALY MARGULIS MD ASSOCIATE PROFESSOR UROLOGIC ONCOLOGY discusses Why Use Systemic Therapy Before Surgery?. At Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL on Sep... Author: kidneycancer Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Radiotherapy In Kidney Cancer
VITALY MARGULIS MD ASSOCIATE PROFESSOR UROLOGIC ONCOLOGY discusses Radiotherapy In Kidney Cancer. At Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL on September 22, ... Author: kidneycancer Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

EA8143 PROSPER RCC: Adjuvant Therapy with a Twist
VITALY MARGULIS MD ASSOCIATE PROFESSOR UROLOGIC ONCOLOGY discusses EA8143 PROSPER RCC: Adjuvant Therapy with a Twist. At Kidney Cancer Association National Patient and Caregiver Conference Chicago, ... Author: kidneycancer Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Objective Response Rate, Best Indicator?
Chung-Han Lee, MD/PhD Memorial Sloan Kettering Cancer Center Discusses Objective Response Rate, Best Indicator? At Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL on ... Author: kidneycancer Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Combinations in Kidney Cancer, Who Benefits?
Chung-Han Lee, MD/PhD Memorial Sloan Kettering Cancer Center Discusses Combinations in Kidney Cancer, Who Benefits? At Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL... Author: kidneycancer Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Combination, TKI, Immunotherapy Efficacy
Chung-Han Lee, MD/PhD Memorial Sloan Kettering Cancer Center Discusses Combination, TKI, Immunotherapy Efficacy. At Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL on... Author: kidneycancer Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Von Hippel-Lindau Disease
Jose A. Karam, MD, FACS Associate Professor Departments of Urology and Translational Molecular Pathology Discusses Von Hippel-Lindau Disease. At Kidney Cancer Association National Patient and Caregive... Author: kidneycancer Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Localized Recurrence Is Rare In An Isolated Fashion
Jose A. Karam, MD, FACS Associate Professor Departments of Urology and Translational Molecular Pathology Discusses Localized Recurrence Is Rare In An Isolated Fashion. At Kidney Cancer Association Nat... Author: kidneycancer Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Whole genome sequencing opens door for targeted Waldenstrms therapy
Steven Treon, MD, PhD, of the Dana-Farber Cancer Institute, Boston, MA, outlines the current outlook of Waldenstrms macroglobulinemia (WM), from hand-me-down to targeted approaches. The discovery ... Author: VJHemOnc Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Updated POLLUX results for early relapsed myeloma patients
Saad Usmani, MD, of the University of North Carolina School of Medicine, Chapel Hill, NC, updates us at the European School of Haematology (ESH) International Conference on Multiple Myeloma 2018, held... Author: VJHemOnc Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Targeting BCMA with bispecific antibodies in R/R myeloma
Saad Usmani, MD, of the University of North Carolina School of Medicine, Chapel Hill, NC, presents exciting results from clinical trials for bispecific antibodies targeting BCMA at the European School... Author: VJHemOnc Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Monoclonal antibodies: current and future potential
Approved monoclonal antibodies for multiple myeloma (MM) are currently available, yet there are still gaps to explore in this therapeutic area for MM. At the European School of Haematology (ESH) Inter... Author: VJHemOnc Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Plasma cell leukemia and extramedullary disease in multiple myeloma
What is the current treatment landscape for plasma cell leukemia and extramedullary disease in multiple myeloma (MM)? We spoke to Niels van de Donk, MD, PhD, of VU University Medical Center, Amsterdam... Author: VJHemOnc Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Judging the value of a clinical trial in hem-onc
The results of clinical trials are open to interpretation and are dependent upon a vast array of factors, including cohort size, the endpoints chosen and the statistics used to analyze the resulting d... Author: VJHemOnc Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Updated CASTOR analysis: daratumumab plus Vd for R/R myeloma
Maria-Victoria Mateos, MD, PhD, of the University of Salamanca, Salamanca, Spain, discusses the updated analysis of the CASTOR trial (NCT02136134) with us at the European School of Haematology (ESH) I... Author: VJHemOnc Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Future treatment combinations for myeloma
Multiple myeloma (MM) therapy has evolved rapidly in recent years, and is showing no sign of slowing. Here, Kenneth Anderson, MD, from Harvard Medical School, Boston, MA, discusses interesting future ... Author: VJHemOnc Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Continuous vs. fixed duration therapy for multiple myeloma?
Speaking from the European School of Haematology (ESH) International Conference on Multiple Myeloma 2018, held in Mandelieu, France, Jess San Miguel, MD, PhD, of the University of Navarra, Pamplona, ... Author: VJHemOnc Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Treatment sequencing in multiple myeloma: a multitude of options
Heinz Ludwig, MD, PhD, from Wilhelminen Cancer Research Institute, Vienna, Austria, discusses treatment sequencing in multiple myeloma (MM). Dr Ludwig covers the many options available to treat MM, pa... Author: VJHemOnc Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts

The evolving imaging of multiple myeloma
Speaking from the European School of Haematology (ESH) International Conference on Multiple Myeloma 2018, held in Mandelieu, France, Evangelos Terpos, MD, PhD, of the University of Athens, Athens, Gre... Author: VJHemOnc Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts